Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation

被引:1
|
作者
Hagen, Julia M. [1 ]
Sutterland, Arjen L. [1 ]
Schirmbeck, Frederike [1 ,2 ]
Cohn, Danny M. [3 ]
Lok, Anja [1 ,4 ]
Tan, Hanno L. [4 ,5 ,6 ]
Zwinderman, Aeilko H. [7 ]
de Haan, Lieuwe [1 ,2 ,4 ]
机构
[1] Univ Amsterdam, Dept Psychiat, Amsterdam UMC, Amsterdam, Netherlands
[2] Arkin Mental Hlth Inst, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Vasc Med, Amsterdam UMC, Amsterdam, Netherlands
[4] Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[5] Univ Amsterdam, Heart Ctr, Dept Cardiol, Amsterdam UMC, Amsterdam, Netherlands
[6] Netherlands Heart Inst, Utrecht, Netherlands
[7] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam UMC, Amsterdam, Netherlands
关键词
Mood disorders; Anxiety disorders; Advanced glycation end products; Oxidative stress; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; RISK-FACTORS; DSM-IV; DEPRESSION; ANXIETY; ACCUMULATION; ASSOCIATION; MORTALITY;
D O I
10.1016/j.jad.2020.07.108
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Skin autofluorescence (SAF), indicating concentration of advanced glycation end products in the skin and oxidative stress, is cross-sectionally associated with affective disorders. Prospective studies of oxidative stress markers will help to clarify the pathophysiological role of oxidative stress. Methods: Data of a population-based cohort study were used. Presence of major depressive disorder, dysthymia, generalised anxiety disorder, panic disorder or social phobia was assessed at baseline and at 5-year follow-up with the Mini-International Neuropsychiatric Interview. Associations between SAF at baseline and incidence and persistence/recurrence of affective disorders were assessed with logistic regression. Results: Of 43,267 participants with no disorder at baseline, 2885 (6.7%) developed an incident disorder during follow-up. In 1360 of 3648 participants (37.3%) with an affective disorder at baseline, a persisting/recurrent disorder was present at follow-up. A modest association existed between SAF and incident affective disorders (OR=1.07 [95%CI 1.03-1.12], P<.001), specifically major depressive disorder (OR=1.11 [95%CI 1.04-1.19], P=.003); this association lost statistical significance after adjustment for sociodemographic factors. Associations between SAF and persistence/recurrence were not significant. Limitations: Many confounders might also act as intermediate: extensive adjustment for confounders caused overfitting and possibly masked effects of SAF on course of affective disorders. Relatively small sample sizes for analyses of SAF and persistence/recurrence of affective disorders resulted in a low power. Conclusions: Increased SAF modestly raises the odds of incident affective disorders, particularly major depressive disorder, providing evidence that oxidative stress plays a role in subsequent occurrence of affective disorders. However, significance of effects faded after adjustment for socioeconomic status.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 50 条
  • [21] Non-invasive Method for Detecting Skin Autofluorescence of Advanced Glycation End Products
    Liu, Yong
    Zhang, Long
    Zhu, Ling
    Wang, Yikun
    Wang, An
    Yu, Feng
    PROCEEDINGS OF THE 2009 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS, VOLS 1-4, 2009, : 1035 - +
  • [22] Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population
    Rajaobelina, Kalina
    Cougnard-Gregoire, Audrey
    Delcourt, Cecile
    Gin, Henri
    Barberger-Gateau, Pascale
    Rigalleau, Vincent
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2015, 70 (07): : 841 - 846
  • [23] Advanced glycation end products measured by skin autofluorescence are associated with melancholic depressive symptoms - Findings from Helsinki Birth Cohort Study
    Eriksson, Mia D.
    Eriksson, Johan G.
    Kautiainen, Hannu
    Salonen, Minna K.
    Mikkola, Tuija M.
    Kajantie, Eero
    Wasenius, Niko
    von Bonsdorff, Mikaela
    Laine, Merja K.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2021, 145
  • [24] Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study
    Tabar, Mohsen Shaygan
    Nilghaz, Maryam
    Hekmatdoost, Azita
    Pashayee-Khamene, Fereshteh
    Mokhtari, Zeinab
    Karimi, Sara
    Ahmadzadeh, Saleheh
    Saberifiroozi, Mehdi
    Hatami, Behzad
    Yari, Zahra
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
    Arsov, Stefan
    Graaff, Reindert
    van Oeveren, Wim
    Stegmayr, Bernd
    Sikole, Aleksandar
    Rakhorst, Gerhard
    Smit, Andries J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (01) : 11 - 20
  • [26] Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study
    Pearce, Colin
    Islam, Naorin
    Bryce, Robyn
    McNair, Erick Donnell
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2018, 27 (04) : 213 - 222
  • [27] Association of physical fitness with skin autofluorescence-derived advanced glycation end products in children
    Kochli, Sabrina
    Endes, Katharina
    Trinkler, Marina
    Mondoux, Morgane
    Zahner, Lukas
    Hanssen, Henner
    PEDIATRIC RESEARCH, 2020, 87 (06) : 1106 - 1111
  • [28] Increased skin autofluorescence of advanced glycation end products (AGEs) in subjects with cardiovascular risk factors
    Sakly, Rim
    Wolffenbuttel, Bruce H. R.
    Khochtali, Ines
    Bouida, Wahid
    Boubaker, Hamdi
    Nouira, Semir
    Abid, Salwa
    Kerkeni, Mohsen
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (04) : 613 - 620
  • [29] Skin autofluorescence is high in patients with cirrhosis - Further arguing for the implication of Advanced Glycation End Products
    Maury, Elisa
    Vergniol, Julien
    de Ledinghen, Victor
    Rigalleau, Vincent
    JOURNAL OF HEPATOLOGY, 2011, 54 (05) : 1079 - 1080
  • [30] Advanced Glycation End Products Assessed by Skin Autofluorescence: A New Marker of Diabetic Foot Ulceration
    Vouillarmet, Julien
    Maucort-Boulch, Delphine
    Michon, Paul
    Thivolet, Charles
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (07) : 601 - 605